Skip to content

Semaglutide

Semaglutide, sold as Rybelsus, is a GLP-1 receptor agonist tablet used for Type 2 Diabetes Mellitus, in 3 mg, 7 mg and 14 mg strengths.

Rybelsus

Type 2 Diabetes Mellitus

3mg · 7mg · 14mg

Semaglutide tablets for type 2 diabetes. It mimics a gut hormone to release more insulin and slow stomach emptying.

From$14.67/ tabletView

Key points

  • Acute pancreatitis has been reported with GLP-1 receptor agonists, including necrotising cases and fatal outcomes.
  • The symptom to watch for is persistent, severe abdominal pain.
  • Semaglutide has not been studied in people with a history of pancreatitis and should be used with caution in those cases.

How does semaglutide work?

Semaglutide mimics GLP-1, a hormone your gut releases after eating. It increases insulin release when blood sugar is high, reduces the sugar your liver sends into the bloodstream, and slows how quickly the stomach empties. Together these effects lower blood sugar after meals and between them, which is why it sits in the Diabetes Management category.

Further reading

Related articles